Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Show me one instance where I’ve been proven wrong in my assessment of Missling’s performance. Just one.
Instead of taking your frustrations out on me, why don’t you direct your ire where it belongs, at our incompetent CEO whose fumbles, stumbles, horrible communications, goal post moving, cherry picking of data, and fibs have cost you and other stockholders dearly?
The stock isn’t where it is because Blackrock is undermining the stock so it can buy cheaper shares. That’s a cop out. It’s because Missling has lost all credibility with biotech investors through the above. Worse, our complacent board of directors hasn’t done a damn thing about it. They have utterly failed in their fiduciary responsibility to enhance shareholder value.
There are no conspiracies against Anavex. There is only demonstrable incompetence.
It’s a sorry state of affairs we find ourselves in.
Sorry if that’s a hard pill to swallow.
DOG bless,
Dream on if it makes you feel better, ‘cause that’s all you got.
DOG bless,
Easy. Because I think the science is interesting and may have potential but I have very little confidence in management’s ability to successfully execute based on a long track record of fumbles, stumbles, missed deadlines, goal post moving, cherry picking of data, terrible communications, and outright fibs. Is that clear enough for you?
Let me ask you a question. Why does somebody who thinks the stock market and the pharmaceutical industry are utterly corrupt participates in the market and invests in biopharma?
Clearly there are other ways to invest your money if that’s what you want to do.
Good licks and DOG bless,
I’ve attended many annual meetings over the years. Some were informative and others mostly perfunctory. I went to an Anavex annual meeting once during a business trip to New York. It was a waste of time, just like the quarterly calls. Not a single executive or director other than Missling showed up. Plus the coffee was luke warm.
Once was enough, thanks.
Since you apparently live in New York, why don’t you attend and let us know your thoughts?
DOG bless,
Apparently it does not concern him. He seems to believe it’s preferable to stand his ground and lose money than to face the fact that Missling has been a rolling disaster for shareholders.
DOG bless,
Since George is hiding out today in shame, I’ll fill in for him. Expect a surge of buying volume in the last 10 minutes of trading with the stock close to at the intraday high on buying volume of close to 2 million shares.
DOG bless,
Again, you defend Missling at your financial peril. I guess you’re just fine with owning a sickly stock that’s going nowhere fast. Me, I'm in it to make as much money as possible. I expect peak performance from the management of any public company I own. I don’t think that’s asking too much. Officers and directors have a fiduciary obligation to enhance shareholder value. On that score, management and the directors of Anavex have failed miserably.
Maybe instead of getting your back up and being so defensive, you could start acting like a shareholder and demand top performance from officers and directors and hold them accountable when they fall flat.
Anavex can and should do better on behalf of shareholders and we should collectively demand they do better.
By the way, I’m in a good mood today because I’m up $86,000 today on Nvidia’s earnings report. Now that’s a great company. As far as Missling goes, I don’t care about his hairdo (though I admit I’m jealous). I also don’t care about that ridiculous white vest he wears under a suit (though he could use some fashion advice from Rebowe).
DOG bless,
I have consistently voted against the directors (which includes Missling) at the annual meetings for several years. I have urged others here to do the same. Since most retail shareholders (and index funds) reflexively vote in line with management’s recommendations (any company, not just Anavex), this effort has failed thus far. I’m not sure what else there is to do but I’m open to your suggestions. It would be great if Missling would take questions from retail shareholders on the quarterly calls and allow them to ask hard questions and hold his feet to the fire but of course that will never happen. Missling prefers to hear Soumit Roy reflexively offer congratulations on all the progress. I do think the market has voted with its feet, however, plus there is little reason right now to buy tiny, development stage, high-risk biopharmas like Anavex when you can put money to work in mutual funds or Vanguard index funds and do better, get some dividends, and sleep better at night.
DOG bless,
Excuses, excuses, excuses. The Missling apologists like you can never find fault and can never hold Missling accountable. You do know that there is such a thing as English lessons to improve the communication skills of anyone whose native tongue is not English, right? Missling wouldn’t even have to pay for lessons out of his own bank account. It would be a reasonable corporate expense. Why? Because effective communications is in everyone’s interest (unless of course you don’t want to be too clear).
And by the way, there are corporate communications professionals who do a great job of teaching executives how to speak and present more effectively. Of course, it takes a commitment of time and effort to improve, which seems to be antithetical to the way Hair Doctor does things.
When are you and other Missling apologists going to start demanding better from our CEO instead of always letting him off the hook? It’s your Money at stake, after all.
DOG bless,
Good luck. Any correspondence sent to the company’s office address would be deposited in the circular file. Missling would never forward any correspondence to the directors.
DOG bless,
I agree. Bishop sounded flummoxed and frustrated with Missling’s non answers. Bishop has staked a lot of his reputation on Anavex/Missling. Touting a loser like Anavex in his newsletter is a great way for him to lose subscribers. He probably wishes he’d never hear of Anavex.
DOG bless,
bas2020 = bs2024. There is no “we”. If there ever was an investment group, which we highly doubt, they’ve long since sold and stopped talking to you.
DOG bless,
I’ve spent considerable time online trying to find contact information for Missling and the directors without success. These folks don’t want to be contacted directly by shareholders. Is it any wonder?
Maybe you can be more successful finding their contact info. If so, please let the rest of us know.
DOG bless,
Not to worry. George will be back. It’ll be the same old, same old. Expect HUGE news this week, next week, soon very soon, the Excellence trial did not fail, Anavex is one of the world’s greatest companies and Missling is one of the world’s greatest CEOs, and he’ll keep posting videos of long dead patients who were seemingly miraculously cured by A2-73, etc.
The pay is simply too good. To hell with integrity and reputation.
To paraphrase George, Good licks and DOG bless,
You have absolutely no idea how index funds work. You are assuming something (Blackrock is beating down the stock price so they can buy cheap) with no basis in reality simply because it fits into the WGT narrative.
Blackrock is the world’s largest asset manager with over $10 trillion under management. Anavex is the equivalent of a grain of sand on a beach. Do yourself and others a favor and do some research on how index funds work. Here’s a start: https://www.investopedia.com/terms/i/indexfund.asp#:~:text=An%20index%20fund%20is%20a,expenses%2C%20and%20low%20portfolio%20turnover.
DOG bless,
Most here assume peer-reviewed papers are always positive and that any paper peer reviewed Anavex paper will be definitive. However, it is not necessarily true that peer-reviewed papers are the final word.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1420798/
https://s4be.cochrane.org/blog/2018/01/16/peer-review-and-publication-does-not-guarantee-reliable-information/
https://www.mcgill.ca/oss/article/critical-thinking-health-and-nutrition-general-science/finding-paper-pubmed-does-not-mean-paper-any-good
There are lots more like this.
I’m not saying Anavex’s peer-reviewed paper (if it is ever published) will be flawed. I’m only suggesting a healthy dose of skepticism.
DOG bless,
“I wish the company were more precise in matters like these.”
Missling specializes in being opaque. Clarity is his enemy. He prefers to leave everything he says open to interpretation. “I hope you’re as excited as we are” is just one example of many.
DOG bless,
Yes. bs2024 is loading up with his endless supply of dry powder.
DOG bless,
Absolutely ridiculous conspiratorial nonsense with no basis in reality or precedence. Big pharma is not in cahoots with Blackrock nor would Blackrock be involved in such a scheme. If any big pharma thought Anavex had the goods, they’d have partnered with the company or happily bought the company at a premium by now.
The stock price and light volume tell me Anavex has no credibility with major biotech investors or big pharma. The AD, PDD, and/or Rett clinical data would have to be bullet proof, irrefutable, and reproducible by independent third parties before anybody would even consider making a move on the company.
Maybe we’ll get there someday but we’re sure not there yet.
DOG bless,
Thanks but that doesn’t answer my question. You say you believe what you wrote, so why are you in the stock market? You could be invested in real estate, US treasuries, or many other things.
DOG bless,
Every time bs2024 announces he’s putting dry powder to work, the stock goes down. It literally never fails. And for the record, not one of his predictions about the timing of regulatory approval has ever come true. (I know b/c I’ve tracked them for years.)
I’ve never known anybody who managed to make money by chasing stocks lower. It seems like a losing strategy to me. I guess there’s some benefit to taking a tax-loss.
DOG bless,
If you really believe that, why are you in the stock market? After all, there are other investment opportunities out there.
DOG bless,
The issue is not whether Anavex should or would move out of New York. I agree with you that that is not going to happen.
The issue is that you need to apologize for your BS prediction that the AD peer-reviewed paper would be published last week online, especially to any investors who bought because of you. A little show of contrition and a promise to stop making nonsensical predictions would be a welcome change of pace.
We’re waiting for you to put on your big-boy pants.
Good licks and DOG bless,
It’s important to continue to try to keep George honest and to not let him get away with his racket. Calling him out won’t change his behavior but it might help some investors side step the con.
You’d think most people would be smart enough to see through George’s obvious attempts to manipulate the stock price so that he can day trade to his benefit (at their expense) but you’d be wrong. There’s a sucker born every minute. Missling, Georgejjl, and bs2020 count on it and profit from it.
DOG bless,
New York taxpayers pay far more to the federal government than they take in. If not for New York taxpayers, most the rest of the country would have to find a way to be self sustaining.
DOG bless,
That’s just beyond ridiculous. Why are you ragging on New York? Have you ever been there? Where should Anavex go? Carmel, Indiana? Fisher, Indiana? I hear there’s office space available at 14074 Trade Center Drive. There’s a world-class medical research industry located there and lots of work for aging fashion models.
Good licks and DOG bless,
Nobody is denying Blarcamesine to anyone. Missling hasn’t filed a New Drug Application. Unless and until he does, there will be no review or potential approval. This is how it works, unless you’d like to go back to snake oil salesmen selling weird and dangerous concoctions on the street. There is no one to hold accountable here except Missling. This is not the first time you have gone on this same rant. I don’t understand why this is so difficult for you to understand. Call or email Missling and ask him what the hold up is.
Good licks, DOG bless, and where is Georgejjl’s apology for lying to everyone to expect a peer-reviewed paper online last week?
That “great information” provided to you by the biggest pumper and Missling apologist ever to infest a message board is propaganda written by a guy who claims to be a defense intelligence analyst who has no medical background and no objectivity when it comes to Anavex whatsoever. MayoMobile never has any criticism of Anavex and never writes about anything in the space other than Anavex. Do what you want with your money but be careful who you lean on for advice when it comes to your investment decisions. Do your own due diligence from independent sources and medical journals.
DOG bless,
Sad but hardly surprising.
DOG bless,
Admit to being wrong about the online publication of a peer-reviewed paper this week and apologize. It’s not so hard. You might even feel better.
We’re waiting.
Good licks and DOG bless,
AVXL closed at $5.67, down 16 cents, on 776K shares sold. No surprise, you were wrong AGAIN.
Where’s our peer-reviewed article that you swore would be published online this week?
Admit that you were wrong. Admit that you made it up. We are waiting!
GOOD LICKS and DOG bless,
I have no interest in being CEO. It’s not in my experience or areas of expertise.
Not wanting to be CEO doesn’t disqualify me from having an opinion of current management. As I’ve said previously, management consulting is in my professional background. I’ve worked directly with CEOs and senior executives on management issues. I know a good CEO and the qualities a good CEO brings when I see one. Missling ain’t it.
DOG bless,
This has nothing to do with a quiet period. IR is free to take calls and respond where appropriate and within limits even during quiet periods.
Even if IR was uncomfortable having any conversations during a quiet period, there is nothing wrong with saying something like: Thanks for your email. We appreciate your interest in Anavex. Due to being in a quiet period ahead of quarterly earnings, I cannot respond to inquiries at this time. After we announce our upcoming earnings report, I will be happy to have a conversation.
Radio silence is rude and unnecessary.
DOG bless,
I believe our CEO is incompetent and our board of directors are complacent and should be replaced. Our CEO has demonstrated gross incompetence over and over again, to the detriment of shareholder value. That is not spin. That is fact. Advocating for a qualified CEO to be hired is also not spin. I want Anavex to succeed. I just don’t have any reason to believe our CEO can get us there. Conversely, there are a hundred reasons to think he won’t get us there. You might also notice that I’ve never urged people to sell their stock. All I’ve said is do your own due diligence, don’t succumb to hype, and don’t bet your financial future or retirement on this or any other similar stock.
Lastly, I sleep at night, so I don’t post 24/7.
Good licks and, as always, DOG bless,
Well, apparently Georgejjl thinks pumping is effective. Otherwise, why would he do it here and on other stock message boards?
DOG bless,
Separating the roles of chairman and CEO is considered best practice. More and more companies are implementing this best practice. That is why the chairman’s role was “taken away” from Missling. The implication that Missling was removed as chairman and replaced by Ma as some sort of punishment or recognition of incompetence or simply being spread too thin is speculative and unsubstantiated.
Chairman Ma is not a magician. She is not going to get a buyout in China, nor in Europe, nor anywhere else. What is that any company going to buy? An unproven drug with unproven science? How much above cash per share would that really be worth? The Chinese aren’t stupid.
DOG bless,
I don’t think Missling is running a Ponzi scheme like Madoff did. He’s just incompetent. He’s a first-time CEO who has impressive sounding educational degrees but no real-world qualifications to run a company or serve as a corporate leader. It’s also clear that in 10 years on the job he has learned nothing nor shown any interest in doing so.
DOG bless,
The PDD data set is here: https://en.m.wikipedia.org/wiki/Mariana_Trench
DOG bless,
Sorry. I’m not good at interpreting Missling’s words or understanding his intended meanings. Maybe he should stick to German and hire an English translator.
DOG bless,
I’ve never understood why people who believe the “system” is sick would nevertheless invest in the biopharma space. Seems like a losing proposition if true. There are lots of other sectors to make money in such as oil and gas, tech, and real estate. Anybody who really believes biopharma is totally sick and corrupt should look elsewhere. Don’t you think? Maybe you could explain it to me.
Good licks and DOG bless,